COVID-19 Vaccines with WHO Emergency Use Listing
| Vaccine | WHO EUL Holder | NRA of record | Date of EUL Recommendation |
|---|---|---|---|
| COMIRNATY® COVD-19 mRNA Vaccine (nucleoside modified) |
BioNTech Manufacturing GmbH |
31 December 2020
16 July 2021 |
|
|
VAXZEVRIA
|
AstraZeneca AB / SK Bioscience Co. Ltd
|
Ministry of Food and Drug Safety (MFDS) Ministry of Health, Labour and Welfare Therapeutic Goods Administration
|
15 April 2021
21 August 2021
23 December 2021
|
|
COVISHIELD™
|
Serum Institute of India Pvt. Ltd | Central Drugs Standard Control Organization | 15 February 2021 |
| COVID-19 Vaccine (Ad26.COV2-S [recombinant]) | Janssen–Cilag International NV | European Medicines Agency | 12 March 2021 |
| SPIKEVAX COVID-19 mRNA Vaccine (nucleoside modified) |
Moderna Biotech
|
30 April 2021
|
|
| Inactivated COVID-19 Vaccine (Vero Cell) | Beijing Institute of Biological Products Co., Ltd. (BIBP) | National Medicinal Products Administration (NMPA) | 07 May 2021 |
| CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated |
Sinovac Life Sciences Co., Ltd | National Medicinal Products Administration (NMPA) | 01 June 2021 |
| COVAXIN® Covid-19 vaccine (Whole Virion Inactivated Corona Virus vaccine) |
Bharat Biotech International Ltd | Central Drugs Standard Control Organization |
03 November 2021 |
COVOVAX™ COVID-19 vaccine (SARS-CoV-2 rS Protein Nanoparticle [Recombinant]) |
Serum Institute of India Pvt. Ltd | 17 December 2021 | |
|
NUVAXOVID™ |
Novavax CZ a.s. | European Medicines Agency | 20 December 2021 |
|
CONVIDECIA COVID-19 Vaccine, (Ad5.CoV2-S [Recombinant]) |
CanSino Biologics Inc. | National Medical Products Administration (NMPA) | 19 May 2022 |